287410 — Jeisys Medical Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid Cap

Annual cashflow statement for Jeisys Medical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	39.6	-21.2	13,493	27,012	25,108
Depreciation
Amortisation
Non-Cash Items	-93.2	-81.2	11,427	9,931	12,851
Unusual Items
Other Non-Cash Items
Changes in Working Capital	107	116	-7,129	-15,217	-9,846
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	53.1	13.7	20,264	24,767	32,376
Capital Expenditures	—	—	-2,784	-13,512	-15,018
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-105	-1,105	8,464	-7,587	-2,642
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-105	-1,105	5,681	-21,099	-17,660
Financing Cash Flow Items	—	—	-8,219	-407	-10,376
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	—	—	-9,309	2,018	-5,092
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-52.3	-1,091	16,700	5,292	9,247